Renol Polychem IPO Listing at 0% Premium at ₹105 Per Share
Posted by : sachet | Thu Aug 07 2025
Renol Polychem IPO listing: The Renol Polychem IPO was subscribed 6.83 times till its closing. In this subscription, 8.41 times were received by the qualified institutional buyers (QIBs) and 6.89 times by non-institutional investors (NIIs). The retail quota of the issue was subscribed to 53.59%. Before delving deeper into the topic, go through the details of the Renol Polychem IPO.
Renol Polychem IPO: It is a bookbuilding IPO of ₹25.77 crore, comprising a fresh issue of 24.54 lakh shares. The issue will be listed on NSE and SME on its tentative listing date, 7th August 2025. The Renol Polychem IPO date is fixed between 31st July 2025 and 4th August 2025. The face value of Renol Polychem IPO shares stands at ₹10 per share, and the IPO price band is set between ₹100 and ₹105 per share.
| IPO Open Date | 31st July 2025 |
| IPO Close Date | 4th August 2025 |
| IPO Allotment Date | 5th August 2025 |
| Refund Initiation | 6th August 2025 |
| Issue Size | 24,54,000 shares(aggregating up to ₹25.77 Cr) |
| Face Value | ₹10 per share |
| Lot Size | 1,200 Shares |
| Issue Price Band | ₹100 to ₹105 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE & SME |
| Listing Date | 7th August 2025 |
Renol Polychem IPO Listing
On the NSE (National Stock Exchange), Renol Polychem is listed at ₹105 per share, reflecting a listing at a premium of 0% against the issue price of ₹105 per share.
About Renol Polychem IPO
Renol Polychem was incorporated in 2008, is engaged in the manufacturing and trading of specialising in colour masterbatches, plastic masterbatches, and industrial chemicals. The company caters to a wide range of customised polymer granules. The main focus of the company is to deliver high-quality products, customised solutions, and focus on sustainability through continuous improvement in innovation and customer-centric production.
- Experienced management team
- Focus on sustainability
- Business expansion plans
- Competitive advantage
- Technological advancement
Renol Polychem Limited Financials
The company’s financial analysis is essential before applying for the Renol Polychem IPO. Look at the table to learn about Renol Polychem Limited’s financials.
| Year Ended | 31st May 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
| Assets | 25.86 | 23.41 | 15.49 | 10.28 |
| Revenue | 12.02 | 62.56 | 6.52 | 41.86 |
| Profit After Tax | 1.14 | 5.00 | 1.53 | 0.73 |
| EBITDA | 1.60 | 7.07 | 2.18 | 1.14 |
| Net Worth | 14.47 | 13.33 | 8.69 | 2.71 |
| Reserve and surplus | 8.98 | 7.84 | 3.20 | – |
| Total Borrowing | 5.28 | 6.95 | 2.58 | 5.36 |
Explanation
Renol Polychem Limited’s revenue soared by 859% from ₹6.52 crores in March 2024 to ₹62.56 crores in March 2025. Moreover, the company’s PAT increased by 226% from ₹1.53 crores to ₹5.00 crores.
Recent Articles
Best Penny Stocks for Long Term in India | Penny Stocks in 2025
Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to ₹314.63 Crore; Revenue Surged 3.55% YoY
Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to ₹35.34 Crore; Revenue Jumps 4.74% YoY
Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to ₹154.38 Crore; Revenue Up 9.54% YoY
Related Posts
Caplin Point Laboratories Q1 Results FY26: Q1 PAT Rises 23.26% to ₹152.80 Crore; Revenue Up 11.17% YoY
Aegis Vopak Terminals Q1 Results FY26: Q1 PAT Rises 85.12% to ₹47.72 Crore; Revenue Up 6.48% YoY
Kirloskar Oil Engines Q1 Results FY26: Q1 PAT Fell 10.94% to ₹6,866.26 Crore; Revenue Up 8.08% YoY
IRCON International Q1 Results FY26: Q1 PAT Fell 260.54% to ₹164.56 Crore; Revenue Down 21.90% YoY
BHEL Q1 Results FY26: Q1 PAT Falls 115.47% to -₹455.50 Crore; Revenue Down 0.04% YoY